Scale-up. Learning how to effectively scale up is a crucial aspect of life-science biotechnology company development. Due to high demand
projections in this area, industry professionals must be prepared to adapt. Scale-up acceleration depends largely on the ability
to define and control processes that produce similar products as those obtained at small scale. For a smooth transition to
occur, industrial engineers assist in the implementation of creating high-tech production processes, while scientists take
care of late-stage development, ensuring smooth implementation of final phase (III and IV) clinical trials as well as compliance
with regulatory demands.
Partnerships. Along the biotechnology company cultivation path, industry professionals must form partnerships that help them attain their
development goals. Companies such as Burrill & Company and LSGPA assist life science companies in the development of these
strategic partnerships that provide access to resources, marketing tools, funding, intellectual property licensing, and technologies
or other alliances necessary for realizing their business plans.
Regulation. Life-science biotechnology companies must consider strategies for streamlining FDA approval, reimbursement, clinical trial
design, product liability, and insurance concerns throughout the entire growth process. This will not only encourage efficiency
in terms of commercialization, but it will also help with safety issues and decrease overall liabilities.
The future of life-sciences biotechnology companies in the 21st century is promising. Modern science and medicine in Karl
Ereky's "biotechnology age" continue to flourish and revolutionize the manner in which the global community thinks about the
healthcare industry. Over the next 10 years, we will undoubtedly continue to see product growth in this area as well as advancements
in how these technologies develop from start to finish. INTERPHEX will continue to be a resource and reflect as well as represent
cutting-edge thought leaders and technology for the pharmaceutical and biotech markets.
RJ Palermo is the event director for INTERPHEX, tel. 203.840.5924, email@example.com
http://Biotechnology.Reference.com/. Wikipedia, the free encyclopedia. http://
http://www.reference.com/browse/wiki/Biotechnology (accessed: Jan. 2007).